🚨 Novedad en China 🇨🇳
Nuevos fármacos e indicaciones aprobados: de asma y sinusitis crónica a psoriasis e hidradenitis supurativa.
🌍 Más acceso a terapias innovadoras para enfermedades inflamatorias.
#ChinaPharma #PharmaNews #Biológicos #NuevosMedicamentos #DengYueMed
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
Journey Medical Misses EPS by $0.50: Journey Medical missed EPS by $0.50 and reported revenue below estimates on Mar 26, 2026 (Investing.com); investors should review the company’s 8-K and guidance for line-item… 👈 Read full analysis #JourneyMedical #EPSMiss #Investing #PharmaNews #RevenueReported
Corcept Gains FDA Approval for Cancer Therapy: Corcept received FDA approval on Mar 25, 2026; shares rose ~28% intraday and market cap expanded by ~$600m, accelerating commercial and strategic options for… 👈 Read full analysis #Corcept #FDAApproval #CancerTherapy #PharmaNews #HealthcareInnovation
#Keytruda #pembrolizumab #immunotherapy #headandneckcancer #PharmaNews #MSD #NICE #reimbursement #NICEfinaldraftguidance #NHSEngland #headandnecksquamouscellcarcinoma #HNSCC #LAHNSCC #PDL1biomarker #PD1inhibitor #KEYNOTE689trial #perioperativeimmunotherapy #PDL1positiveHNSCC
zurl.co/y2cQh
Merck Nears Deal to Buy Terns Pharmaceuticals: Bloomberg reported on Mar 25, 2026 that Merck is in advanced talks to acquire Terns Pharmaceuticals; watch filings and deal structure for valuation impacts. 👈 Read full analysis #Merck #TernsPharmaceuticals #Biotech #MergersAndAcquisitions #PharmaNews
Crinetics Pharma COO to Step Down, Shares Weaken: Crinetics announced a COO departure on Mar 23, 2026; Nasdaq-listed CRNX saw elevated intraday volume and volatility, per Seeking Alpha and exchange data. 👈 Read full analysis #CrineticsPharma #COO #Nasdaq #CRNX #PharmaNews
Gilead Nears $2bn Ouro Medicines Deal: Gilead is reported to be nearing a $2.0bn acquisition of Ouro Medicines (FT, Mar 23, 2026); the deal would be a targeted bolt-on versus Gilead's $21bn Immunomedics purchase in… 👈 Read full analysis #Gilead #OuroMedicines #Acquisition #PharmaNews #Healthcare
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
ESA de acción prolongada de Sansheng Pharma (Rosai EPO alfa / Xinbi’ao) aprobada para anemia por ERC en hemodiálisis 💊
¿Menos dosis y mejor control de Hb?
🎥 Mira el video
#CKD #AnemiaRenal #Hemodiálisis #ESA #PharmaNews #Biopharma
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
FDA Flags Aurobindo Pharma Unit In Rajasthan
Full Story: indiawest.com/fda-flags-au...
#FDA #AurobindoPharma #PharmaNews #NewDelhi #BusinessNews #HealthcareIndustry #DrugSafety #RegulatoryUpdate #Pharmaceuticals #IndiaBusiness
🔗 Read more: bit.ly/ONCOnews-19M...
#ONCOnews #OncoAlert #OncEd #OvarianCancer #CancerResearch #Oncology #PrecisionMedicine #PersonalizedMedicine #CompanionDiagnostics #Biomarkers #TargetedTherapy #CancerCare #OncologyNews #ClinicalTrials #DrugDevelopment #FDAApproval #PharmaNews #MedTech
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
Iran-US can be reason for medicine price hike in India
#MedicinePrices #PharmaNews #IndiaNews #IranUSConflict #HealthcareCosts #SupplyChain #BreakingNews #GlobalEconomy #Pharmaceuticals #InflationImpact
www.indiaweekly.biz/iran-us-conf...
In yesterday's headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
Analysten: Könnte stärker wirken als Eli Lillys Medikament
Der Markt für Abnehmmedikamente wurde bisher von Eli Lilly und Novo Nordisk dominiert – jetzt kommt ein neuer Player! 🚀
Wenn Sobis Medikament zugelassen wird, könnte sich das Marktgefüge komplett ändern. ⚖️
#EliLilly #PharmaNews
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
🔷 Based on Phase 3 VERIFY data, if approved, Rusfertide could become a first-in-class therapy, offering a novel treatment approach for patients requiring improved hematocrit control.
🔗 Read more: bit.ly/ONCOnews03-M...
#ONCOnews #OncoAlert #OncEd #BiotechNews #PharmaNews #Oncology #Hematology
In today’s headlines: pharmaphorum.com/news
#news #pharma #lifesciences #pharmanews #pharmaindustry
